(Q79366427)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Xinkang Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Patricia L Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Mei-Yin Hsu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Joseph A Tamasi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Eileen Bird

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

William A Schumacher

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Thrombolysis

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

41-49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11239-006-9009-4

22 December 2019

exact match

0 references

cites work

Carboxypeptidase B inhibitors reduce tissue factor-induced renal microthrombi in rats

1 reference

12 December 2020

Purification and properties of a carboxypeptidase inhibitor from potatoes

1 reference

12 December 2020

Thrombin-activatable fibrinolysis inhibitor

1 reference

12 December 2020

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)

1 reference

12 December 2020

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

1 reference

12 December 2020

Plasma carboxypeptidases as regulators of the plasminogen system

1 reference

12 December 2020

Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice

1 reference

12 December 2020

In vivo regulation of plasminogen function by plasma carboxypeptidase B.

1 reference

12 December 2020

Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway

1 reference

12 December 2020

Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor

1 reference

12 December 2020

Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin

1 reference

12 December 2020

Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient mice.

1 reference

12 December 2020

Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis

1 reference

12 December 2020

A novel approach to arterial thrombolysis

1 reference

12 December 2020

Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis

1 reference

12 December 2020

Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography

1 reference

12 December 2020

Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation

1 reference

12 December 2020

Synthesis and evaluation of imidazole acetic acid inhibitors of activated thrombin-activatable fibrinolysis inhibitor as novel antithrombotics

1 reference

12 December 2020

Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor

1 reference

12 December 2020

Thrombin-activable fibrinolysis inhibitor levels in the acute phase of ischemic stroke.

1 reference

12 December 2020

Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction.

1 reference

12 December 2020

Enhancement of fibrinolysis by EF6265 [(S)-7-amino-2-[[[(R)-2-methyl-1-(3-phenylpropanoylamino)propyl]hydroxyphosphinoyl] methyl]heptanoic acid], a specific inhibitor of plasma carboxypeptidase B.

1 reference

12 December 2020

Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system

1 reference

12 December 2020

Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life

1 reference

12 December 2020

10.1007/S11239-006-9009-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111204%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference